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Purpose: To introduce a method to efficiently identify and calculate meaningful tradeoffs between
criteria in an interactive IMRT treatment planning procedure. The method provides a systematic
approach to developing high-quality radiation therapy treatment plans.
Methods: Treatment planners consider numerous dosimetric criteria of varying importance that,
when optimized simultaneously through multicriteria optimization, yield a Pareto frontier which
represents the set of Pareto-optimal treatment plans. However, generating and navigating this fron-
tier is a time-consuming, nontrivial process. A lexicographic ordering (LO) approach to IMRT uses
a physician’s criteria preferences to partition the treatment planning decisions into a multistage
treatment planning model. Because the relative importance of criteria optimized in the different
stages may not necessarily constitute a strict prioritization, the authors introduce an interactive pro-
cess, sensitivity analysis in lexicographic ordering (SALO), to allow the treatment planner control
over the relative sequential-stage tradeoffs. By allowing this flexibility within a structured process,
SALO implicitly restricts attention to and allows exploration of a subset of the Pareto efficient fron-
tier that the physicians have deemed most important.
Results: Improvements to treatment plans over a LO approach were found by implementing the
SALO procedure on a brain case and a prostate case. In each stage, a physician assessed the tradeoff
between previous stage and current stage criteria. The SALO method provided critical tradeoff in-
formation through curves approximating the relationship between criteria, which allowed the physi-
cian to determine the most desirable treatment plan.
Conclusions: The SALO procedure provides treatment planners with a directed, systematic process
to treatment plan selection. By following a physician’s prioritization, the treatment planner can
avoid wasting effort considering clinically inferior treatment plans. The planner is guided by crite-
ria importance, but given the information necessary to accurately adjust the relative importance at
each stage. Through these attributes, the SALO procedure delivers an approach well balanced
between efficiency and flexibility.VC 2012 American Association of Physicists in Medicine.
[http://dx.doi.org/10.1118/1.4720218]
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I. INTRODUCTION
When addressing a radiation therapy case, a physician gener-
ally presents the treatment planner with a number of dosimet-
ric goals of varying importance. While the general objective
is to deliver a prescribed radiation dose to the target(s) while
simultaneously sparing critical structures, a major challenge
remains how to make the unavoidable tradeoffs between these
conflicting goals. The literature on radiation therapy treatment
planning as well as clinical treatment planning systems
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contains a multitude of evaluation criteria that can be used to
quantify various properties of a treatment plan. Because treat-
ment planning is generally a time-consuming endeavor which
has to be performed for individual patients, providing a treat-
ment planner with tools that allow for an efficient assessment
of the interplay and tradeoffs between conflicting treatment
plan evaluation criteria is essential to an efficient and effec-
tive treatment planning process.
Traditionally, radiation therapy treatment planning is
based on optimization models containing a single objective
function to be optimized subject to a set of hard constraints
on the treatment plan. The objective function is typically a
simple weighted sum of individual treatment plan evaluation
criteria (see Ref. 1). Since there is no formal basis for choos-
ing a priori values for these weights, their values are usually
updated manually by the treatment planner in an iterative
fashion in order to arrive at a clinically desirable treatment
plan. Occasionally this method yields acceptable results
quickly, but in general this approach is inefficient and may
lead to inferior treatment plans.
A modern technique for exploring the tradeoffs between
treatment plan evaluation criterion is based on multicriteria
optimization (MCO) (see, e.g., Ref. 2 for a recent overview
of this area). In this approach, the goal is to approximate the
Pareto surface containing all efficient treatment plans, i.e.,
treatment plans with the property that it is not possible to
improve the plan with respect to one of the criteria without
deteriorating the plan with respect to at least one other.
While there are many methods for generating this surface
(see, e.g., Ref. 3), a common technique is to solve a
sequence of single-objective optimization problems, each
using an appropriately chosen set of weights for the individ-
ual criteria. When all criteria are convex functions of the
dose distribution delivered to the patient, each of the corre-
sponding solutions will represent a point on the Pareto sur-
face. If the number of such solutions is large enough to
allow the Pareto frontier to be accurately approximated (typ-
ically using interpolation), the treatment planner can assess
the tradeoffs between competing objectives by navigating
the frontier and use this information to select a treatment
plan. Using MCO as a means of quantifying tradeoffs is con-
ceptually attractive, in the sense that it provides the treat-
ment planner with complete and comprehensive tradeoff
information on all criteria. However, the number of compet-
ing criteria can be large (say on the order of 10–25 in a typi-
cal clinical setting), which means that the Pareto frontier is
embedded in a correspondingly high-dimensional space.
Many solutions may then be required to accurately approxi-
mate the Pareto frontier, which reduces its efficiency (see
Ref. 4). Moreover, visualizing and interpreting the plethora
of tradeoffs can prove difficult (see Ref. 5). Of course a
reduction in the number of criteria or data reduction in the
form of a coarser representation of patient geometry and=or
capabilities of the delivery equipment may mitigate these
drawbacks, but this may affect the accuracy of the frontier or
the quality of the tradeoff information (see, e.g., Ref. 6).
A key observation is that the full Pareto frontier identi-
fied by MCO will likely contain many tradeoff regions that
are clinically unacceptable or irrelevant. This not only com-
plicates the navigation process as outlined above but it also
means that a large amount of time may be spent identifying
such uninteresting tradeoffs. It therefore seems appropriate
to explicitly incorporate better a priori clinical information
on priorities associated with the different criteria into the
treatment plan optimization process. One such approach is
lexicographic optimization (LO), which is sometimes also
referred to as prioritized optimization (see Refs. 7–9). This
is a multistage approach that is based on a complete ranking
or prioritization of treatment planning goals. In its purest
form it starts by optimizing the highest ranked criterion.
The optimal value to this problem is then used to constrain
the value of the corresponding criterion in subsequent opti-
mization models. In particular, in the following stage the
second criterion on the prioritized list is optimized subject
to the value of the first criterion being optimal. This
approach is then repeated for each criterion on the list,
and the solution to the final optimization problem in the
sequence is the optimal treatment plan with respect to the
prioritized list of criteria. LO is computationally efficient
and provides a clear, systematic approach. In contrast with
MCO, LO does not rely on interaction with the treatment
planner (once the prioritization is fixed). However, much
flexibility is sacrificed in the wake of the computational
and structural benefits. In particular, a notable drawback
of using an LO approach is that the treatment planner may
be unaware of opportunities that may exist to improve a
treatment plan. In terms of MCO, the LO approach can be
interpreted as confining the treatment planner’s view to a
specific extreme solution on the full Pareto frontier of inter-
criterion tradeoffs. If a minor sacrifice in high-priority
criteria could yield meaningful benefits with respect to
lower-priority criteria, the pure LO approach would not rec-
ognize or identify this opportunity. In order to introduce
some flexibility into the process one might relax the opti-
mality constraint on high-priority criteria and instead
require previously optimized criteria to remain “near-
optimal.” Since tradeoffs are not characterized and assessed
explicitly, it is not clear how to quantify the concept of
near-optimality nor how to predict the consequences
of allowing a deviation from optimality. In contrast, our
method will provide an interactive way for the user to select
the relaxation based on a formal sensitivity analysis.
In this paper, we propose a systematic approach, sensitivity
analysis in lexicographic ordering (SALO), which combines
the benefits of MCO (flexibility and comprehensiveness) and
LO (efficiency and clinical focus) while avoiding their pit-
falls. Similar to LO, it incorporates clinical information
through a prioritized list of treatment plan evaluation criteria.
However, in contrast with LO, it uses this information to, in
an interactive and iterative fashion, efficiently navigate the
clinically interesting and relevant segment of the Pareto effi-
cient frontier. In Sec. II of this paper, we will provide a formal
and detailed description of the SALO approach. In Sec. III,
we will then illustrate the approach on two clinical cases and
discuss SALO. In Sec. IV, we will discuss some implementa-
tion characteristics and conclude the paper.
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II. METHODS AND MATERIALS
The goal of the SALO approach is to provide local infor-
mation on the shape of the Pareto frontier to treatment plan-
ners for use as a decision making aid, based on clinical
preferences represented via a prioritized list of treatment
plan evaluation criteria. This local information takes the
form of a two-dimensional Pareto frontier that, in each stage,
characterizes the tradeoff between two consecutive criteria
while (i) constraining higher priority criteria to values that
have been established earlier in the process and (ii) tempo-
rarily ignoring lower priority criteria. The treatment planner
can then examine this tradeoff curve and select a point that
appropriately captures the tradeoff between the two criteria
currently under consideration. This point then defines an
upper bound for the criterion that has the higher priority.
II.A. Notation and model
Optimization models for radiation therapy treatment plan-
ning are usually classified as “beamlet-based” (yielding an
optimal fluence map, which subsequently needs to be con-
verted into a deliverable plan in a leaf-sequencing stage) and
“aperture-based.” We have chosen to use the latter, direct
aperture optimization (DAO), approach (see, e.g., Refs.
10–13) since it not only eliminates the need for a leaf-
sequencing stage but can also allow for a more efficient
implementation and solution since an instance of the DAO
model is typically much smaller and hence can be solved
more rapidly than an instance of a beamlet-based fluence
map optimization (FMO) problem. This is particularly im-
portant since many of these problems will need to be solved
during the course of the SALO procedure. However, if
desired the general SALO approach can be based on a more
traditional FMO model with only minor modifications.
As is traditionally done in radiation therapy treatment
planning, we discretize the relevant patient geometry into a
finite set of voxels V. Moreover, we assume that there is a fi-
nite set of deliverable apertures K. The dose delivered to
voxel j 2 V from aperture k 2 K at unit intensity is given by
Dkj, which we will refer to as aperture-based dose deposition
coefficients. The decision variables are the aperture inten-
sities, denoted by yk ðk 2 KÞ. For convenience, we will add
as decision variables the dose zj delivered to each voxel
j 2 V. For convenience we will let y ¼ ðyk : k 2 KÞ and
z ¼ ðzj : j 2 VÞ denote the corresponding vectors. Finally,
let Z denote a convex set that excludes all clinically unac-
ceptable treatment plans. Convexity of this set is important
for tractability of our approach, and we usually expect this
set to contain only simple lower and upper bound constraints
on the individual voxel doses. In principle other hard con-
straints on treatment plan evaluation criteria could be
included as well, although we envision those tradeoffs to be
made in the actual SALO procedure rather than by a priori
excluding certain dose distributions.
The treatment plan evaluation criteria are given as functions
of the dose distribution: G‘ : RjVj ! R ð‘ ¼ 1;…; Lþ 1Þ,
where we assume that the criteria are indexed in order of
decreasing priority. For mathematical convenience we will
assume that these criteria are such that smaller values are pre-
ferred to larger values. Of course the essence of our approach
could be generalized to cases where this assumption is vio-
lated, and in fact our examples in Sec. III will include criteria
for which larger values are preferred. In addition, we will gen-
erally assume that they are all convex functions. Note that, in a
multi-criteria context, many common treatment plan evalua-
tion criteria, such as voxel-based penalty functions, (general-
ized) equivalent uniform dose (EUD, gEUD), tumor control
probabilities (TCP), normal-tissue complication probabilities
(NTCP), or conditional value-at-risk (CVaR), are either con-
vex or can equivalently be replaced by convex ones (see
Ref. 14). Our proposed approach could in principle be general-
ized to accommodate a nonconvex set Z and=or truly noncon-
vex criteria, such as traditional dose-volume histogram (DVH)
constraints, albeit at the expense of computational efficiency.
The last criterion, GLþ1, is typically chosen in order to mini-
mize total dose delivered to the patients while maintaining
treatment plan quality with respect to all previously considered
criteria. The SALO approach then interactively searches for a
treatment plan by solving a sequence of bicriteria optimization
models of the following form (for ‘ ¼ 1;…; L) referred to as
stages of the procedure:
minimize G‘ðzÞ; G‘þ1ðzÞf g
subject to ðPð‘ÞÞ
zj ¼
X
k2K
Dkjyk for j 2 V
G‘0 ðzÞ  G‘0 for ‘0 ¼ 1;…; ‘ 1
yk  0 for k 2 K
z 2 Z;
where G‘0 is an upper bound on treatment plan evaluation
criterion G‘0 that is set by solving the prior bicriteria optimi-
zation problem ðPð‘0ÞÞ (for ‘0 ¼ 1;…; ‘ 1) and making the
corresponding tradeoff.
Due to the convexity of the criterion functions, the solu-
tion to the bicriteria optimization problem ðPð‘0ÞÞ can be
found by solving single-criterion optimization problems with
an objective function of the form
aG‘ðzÞ þ ð1 aÞG‘þ1ðzÞ (1)
for all a 2 ½0; 1.
II.B. Sensitivity analysis in lexicographic optimization
If the set of all deliverable apertures is manageable, we
could directly apply the approach outlined above. Unfortu-
nately, in general the cardinality of the set K is very large
and the optimization problems ðPð‘0ÞÞ cannot be solved
explicitly. One potential approach would be to generate
high-quality apertures “on the fly” according to a column
generation approach that has been proposed for solving
single-criterion DAO problems (see, e.g., Refs. 11–13).
However, this would mean that the set of apertures consid-
ered in later stages of the algorithm is different from (in fact,
larger than) the set of apertures allowed in earlier stages.
This means that the tradeoffs between the higher priority,
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and hence clinically more important, criteria are based made
on a more limited set of apertures. Intuitively it would seem
more attractive to base the more important (or, in fact, and
all) tradeoff decisions on the most accurate representation of
the optimization model rather than the least accurate, which
makes a straightforward application of this idea undesirable.
In order to address this issue we propose to start the
SALO procedure with an initial phase in which a high-
quality pool of apertures is generated, which is then kept
fixed throughout the L stages of the SALO procedure. This
does not only improve the computational efficiency of the
approach, but also ensures that all decisions are made based
on consistent input and information. However, it is clear
that, in this process, the tradeoff decisions are not made with
respect to the full information regarding all deliverable aper-
tures. We therefore also propose a final phase in which a full
DAO model is solved to identify a new set of apertures that
minimizes the last criterion, GLþ1, subject to all bounds
imposed on criteria G1;…;GL. Clearly, this final phase could
also take other considerations, such as treatment delivery
efficiency, into account. In summary, we propose a SALO
procedure that proceeds in three phases:
Phase 1. Generation of a clinically relevant aperture pool of
computationally manageable cardinality.
Phase 2. Generation of patient-specific treatment planning
goals G‘ ð‘ ¼ 1;…; LÞ by solving a sequence of bicriteria
optimization problems ðPð1ÞÞ;…; ðPðL1ÞÞ.
Phase 3. Generation of final treatment plan that satisfies the
patient-specific treatment planning goals while minimiz-
ing an overall single objective function.
In the remainder of this section, we will discuss these
three stages in more detail.
II.B.1. Aperture pool generation
We generate an aperture pool by solving a traditional
single-criterion treatment plan optimization model based on
the treatment plan evaluation criteria
minimize
PL
‘¼1
a‘G‘ðzÞ
subject to ðPÞ
zj ¼
X
k2K
Dkjyk for j 2 V
yk  0 for k 2 K
z 2 Z;
where a‘  0 ð‘ ¼ 1;…; LÞ are nonnegative criterion
weights. The set of weights used in the aperture generation
phase could either be based on experience with other, similar,
patient cases. Alternatively, we could use a sequence of crite-
rion weights, allowing for the generation of apertures that are
attractive with respect to a variety of tradeoffs. For conven-
ience, we will denote the set of apertures in the pool by K.
II.B.2. Solving a bicriteria optimization problem
We use the so-called Sandwich Algorithm (see, e.g.,
Refs. 2, 15, and 16) to approximate the Pareto frontier at a
given stage of the SALO procedure. This algorithm, which
tries to balance clinical accuracy and computational effi-
ciency, applies when all treatment plan evaluation criteria
are convex, and is particularly efficient in the bicriteria case.
The idea behind this algorithm is to approximate the entire
Pareto frontier by constructing both an upper (conservative)
and a lower (optimistic) bound on the frontier based on a fi-
nite set of points on the frontier. This is done by solving a
sequence of optimization problems of the form ðPð‘ÞÞ with
objective function of the form (Sec. II.A) for different values
of a. The optimal solutions to these problems yield points
on the Pareto frontier. For convenience, let zða; ‘Þ denote
an optimal solution to ðPð‘ÞÞ when parameter a is used.
Then, let
G‘ða; ‘Þ ¼ G‘ zða; ‘Þð Þ;
G‘þ1ða; ‘Þ ¼ G‘þ1 zða; ‘Þð Þ;
G‘;‘þ1ða; ‘Þ ¼ aG‘ða; ‘Þ þ ð1 aÞG‘þ1ða; ‘Þ:
The Sandwich algorithm then determines upper and lower
bounds on the Pareto frontier as follows.
II.B.2.a. Upper bound. Using simple linear interpolation
of a set of Pareto efficient solutions, we obtain a piecewise-
linear and convex function which is well-known to form an
upper bound on the Pareto frontier. This follows immedi-
ately from the fact that the line segment connecting any two
points of the form G‘ða; ‘Þ;G‘þ1ða; ‘Þ
 
for different values
of a is guaranteed to be entirely on or above the Pareto fron-
tier. More formally, such a line segment can be characterized
as
fðkG‘ ða; ‘Þ þ ð1 kÞG‘ða0; ‘Þ; kG‘þ1ða; ‘Þ
þ ð1 kÞG‘þ1ða0; ‘ÞÞ : k 2 ½0; 1g; (2)
where 0 < a 6¼ a0 < 1. It is interesting to note that we can
find an even better bound on the Pareto frontier by, instead
of interpolating the pairs of optimal objective function val-
ues for different values of a, interpolating the optimal treat-
ment plans (or, equivalently, and optimal dose distributions)
for different values of a. In other words, the curve of the
form
fðG‘ kzða; ‘Þ þ ð1 kÞzða0; ‘Þð ÞG‘þ1 kzða; ‘Þð
þð1 kÞzða0; ‘ÞÞÞ : k 2 ½0; 1g;
where 0 < a 6¼ a0 < 1 is guaranteed to not only be entirely
on or above the Pareto frontier, but also entirely on or below
the curve in Eq. (1).
II.B.2.b. Lower bound. A lower bound can be deter-
mined by observing that the line given by
ag‘ þ ð1 aÞg‘þ1 ¼ G‘;‘þ1ða; ‘Þ (3)
is entirely on or below the Pareto frontier [where g‘; g‘þ1ð Þ
denotes a point inR2]. This follows since (i) the Pareto fron-
tier is convex by convexity of the criteria functions G‘ and
G‘þ1 and (ii) the point G‘ ða; ‘Þ;G‘þ1ða; ‘Þ
 
lies both on the
efficient frontier and the line (2). This means that the upper
envelope of these lines over a collection of different values
of a 2 ð0; 1Þ is a piecewise-linear convex function that is
entirely on or below the Pareto frontier as well.
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II.B.2.c. Choosing objective function weights a. There
are different ways in which the set of values for a to be used
at a particular SALO stage can be determined. In an interac-
tive implementation, the treatment planner could indicate
which value to use with the goal of refining the approxima-
tion of the Pareto frontier in the clinically most relevant or
interesting areas. In an automated setting this can be done by
measuring the discrepancy between the upper and lower
bounds, and choosing that value of a where the discrepancy
is largest. Since the bounds are themselves curves, different
discrepancy measures can be used, and each of them will
yield a different sequence of values for a and a different
bounding of the frontier. However, when designed carefully,
we can ensure that the lower and upper bounds both con-
verge to the Pareto frontier as the number of values for a
increases (see Ref. 17).
II.B.3. Final treatment plan optimization
This full model clearly has a feasible solution (by con-
struction), i.e., by generating a new set of apertures from
scratch we know it will be possible to achieve all previously
identified treatment planning goals. The DAO column gener-
ation procedure can therefore be initialized with the final so-
lution obtained by the SALO procedure. However, if there is
an additional goal related to treatment plan delivery effi-
ciency, such as limiting the beam-on-time or number of
apertures, it may be preferable to discard the original aper-
ture pool and start the DAO algorithm from scratch. Since a
feasible solution is needed to start the procedure, the algo-
rithm is then started by first optimizing an auxiliary problem
of the following form:
minimize
PL
‘¼1
max G‘ðzÞ  G‘; 0
 
subject to ðIÞ
zj ¼
X
k2K
Dkjyk for j 2 V
yk  0 for k 2 K
z 2 Z:
Any feasible solution to this problem with objective function
value 0 is a feasible solution to the actual problem from
which the DAO algorithm can be started.
II.C. Treatment plan evaluation criteria
For our experiments we have chosen to use a single mea-
sure of generalized equivalent uniform dose (gEUD) for each
target and major critical structure as our main treatment plan
evaluation criteria. Letting S denote the set of structures and
Vs the set of voxels in structure s 2 S, the gEUD correspond-
ing to the dose distribution in structure s 2 S is given by
gEUDsðz; asÞ ¼
1
jVsj
X
j2Vs
zasj
 ! 1
as
;
where 1  as  1 if s is a critical structure while
1  as  1 if s is a target, and where
gEUDsðz; asÞ ¼
maxj2Vs zj if as ¼ 1
1
jVsj
P
j2Vs
zj if as ¼ 1
minj2Vs zj if as ¼ 1
8><
>:
(see, e.g., Refs. 18 and 19). For the sake of computational ef-
ficiency, we have chosen to use an approximation of gEUD
given by a convex combination of mean and maximum dose
for critical structures and of mean and minimum dose for tar-
gets (see Refs. 20 and 21). In particular, we choose treatment
plan evaluation criteria functions G‘ of the form
csgEUDsðz; 1Þ þ ð1 csÞgEUDsðz;1Þ
¼ cs
1
jVsj
X
j2Vs
zj þ ð1 csÞmax
j2Vs
zj;
if s is a critical structure, and
csgEUDsðz; 1Þ þ ð1 csÞgEUDsðz;1Þ
¼ cs
1
jVsj
X
j2Vs
zj þ ð1 csÞmin
j2Vs
zj;
if s is a target, where in both cases cs 2 ½0; 1. (Note that,
when s is a target, the criterion described above is a function
for which larger values are preferred to smaller values,
which means that in the optimization problems as described
earlier in this paper, we actually use the negative of this cri-
terion.) The advantage of using these approximations is that
our optimization problems can be formulated and solved as
linear programs.
As our final criterion we have chosen to minimize the
sum of all voxel doses
GLþ1ðzÞ ¼
X
j2V
zj:
Moreover, we assume that no tradeoff takes place
between gEUD-criterion GL and this final criterion GLþ1, so
that, in problem ðPðLÞÞ, we limit ourselves to a ¼ 1 in the
corresponding objective function (Sec. II.A).
II.D. Data and computations
We illustrate our SALO procedure on two clinical cases
from different sites: brain and prostate. The brain cancer
case has 8 beams and 575 beamlets while the prostate cancer
case had 7 beams and 796 beamlets. In both cases, the beam-
lets were of dimension 5 5 mm2, and only beamlets whose
primary trajectory intersected with the target(s) were
included in the model. We chose the set Z to be of the form
Z ¼ z 2 RjVj : zs  zj  zs; j 2 Vs; s 2 S
n o
:
The weighting parameters cs in the gEUD-approximation
described in Sec. II.C were found by evaluating both the
gEUD and its approximation on a clinically acceptable dose
distribution, where suitable values of the gEUD parameters
as were taken from the works of Burman et al.,
22 Lawrence
et al.,23 Mayo et al.,24 Michalski et al.,25 Roach et al.,26 Vis-
wanathan et al.,27 and clinical practice at the University
of Michigan, Department of Radiation Oncology. Table I
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provides, for each of the two cases, the structures and two
prioritization scenarios, as well as the number of voxels jVsj
in each structure s 2 S, the gEUD parameters as and cs, and
the dose upper and lower bounds zs and zs (where the latter
is 0 if omitted). The structures without prioritization values
will be addressed in the final treatment plan optimization,
but not in the interactive portion of the algorithm.
The optimization problems were all optimized on a Mac
Pro 4.1 with a single 2.93 GHz Quad-Core Intel Xeon proc-
essor and 12 GB DDR3 memory at 1066 MHz. All model
generation code was written in Cþþ and executed in Xcode,
and the primal simplex method of CPLEX 12.2 was used as
the solver. Since the number of coefficients Dkj are too
numerous to be precomputed and stored, and since the col-
umn generation relies on an efficient representation of these
coefficients, we make the common assumption that these
coefficients can be expressed in terms of so-called beamlet-
based dose deposition coefficients.
Dkj ¼
X
i2Ak
dij;
where Ak  B is the subset of beamlets that is exposed in
deliverable aperture k 2 K, B is a set of beamlets that discre-
tizes the beams used for treatment, and dij is the dose deliv-
ered to voxel j 2 V from beamlet i 2 B. Storing the
(nonzero) coefficients dij for all j 2 V and i 2 B is managea-
ble in a sparse format. Finally, in Phase 1 of the SALO pro-
cedure we generated a pool of jKj ¼ 100 apertures.
III. RESULTS AND DISCUSSION
In this section, we will describe in detail how the treat-
ment planning process based on the SALO procedure would
proceed in the two clinical cases. We will illustrate the
SALO procedure by going through all steps that a treatment
planner would take when developing a treatment plan. For
both cases, we will show two examples of potential a priori
clinical priority lists, along with a potential sequence of deci-
sions made by the treatment planner, for a total of four
SALO applications. Furthermore, for ease of exposition we
limit ourselves in both cases to a relatively small set of crite-
ria. The tradeoff decisions made during the SALO process
were made by radiation oncologists. Note that, in addition to
the tradeoff curves, in our experiments the treatment plan-
ners were also provided with summary dose distribution
information for the different structures (such as minimum,
maximum, and mean dose, as well as DVH endpoints) dur-
ing the process.
III.A. Brain case
For the brain case, we distinguish L ¼ 5 major gEUD cri-
teria, one for each of the first five structures listed in Table I.
We consider the two alternative priority scenarios A and B
as indicated in that table. Figures 1 and 2 show the L 1
stages of Phase 2 of the SALO procedure for these two sce-
narios, while Fig. 3 shows the final sets of DVH curves.
These curves show how scenario A compares to (a) LO and
(b) scenario B.
Consider scenario A for the brain case in Fig. 1. When
the treatment planner begins the process, Fig. 1(a) is gener-
ated and presented to the planner. The treatment planner
then uses this information to assess the relationship between
the gEUDs delivered to the PTV and the chiasm. In this
instance, the treatment planner used this information to
choose a lower bound on the gEUD to the PTV of 53.96 Gy,
as indicated by the dot. From the graph we can then also con-
clude that this means that the gEUD to the chiasm will have
to be at least equal to 47.94 Gy. The optimization model
then adds the lower bound on the gEUD to the PTV to the
set of constraints and generates Fig. 1(b). As we can see, by
slightly increasing gEUD to the chiasm it is possible to
reduce the gEUD to the brainstem by a meaningful amount.
However, as we allow more dose to the chiasm, the benefit
to the brainstem lessens. Without this accurate information,
the planner would not be able to identify the clinically most
beneficial tradeoff between these two criteria. The treatment
planner then follows this procedure for all other stages.
After optimizing the final criterion (i.e., minimizing the
sum of all voxel doses and generating a new set of apertures
given the chosen gEUD bounds) we obtain a treatment plan
whose DVHs are shown in Fig. 3(a). In addition, the DVHs
obtained by using pure LO are shown as well. We conclude
that, by accepting a minor reduction in PTV dose, all other
TABLE I. Structures with corresponding number of voxels and gEUD-
parameters for the two clinical test cases.
Priority
Site A B Structure ðsÞ jVsj as cs zs zs
Brain 1 2 PTV 6318 15 0.9 63 56
2 1 Chiasm 216 10 0.38 57 —
3 3 Brainstem 1836 10 0.5 60 —
4 4 Optic nerve (contralateral) 218 10 0.54 63 —
5 5 Optic nerve (ipsilateral) 247 10 0.33 63 —
Left eye 363 — — 63 —
Right eye 345 — — 63 —
Left lens 167 — — 63 —
Right lens 136 — — 63 —
Normal tissue ring 1 6723 — — 62 —
(0–1.5 cm from PTV) — — — —
Normal tissue ring 2 4652 — — 57 —
(1.5–3 cm from PTV) — — —
Normal tissue ring 3 13 037 — — 45
(>3 cm from PTV) — — — —
Total 34 258 — — — —
Prostate 1 2 PTV 3586 5 0.3 85.5 73
2 1 Rectum 8766 8 0.4 78 —
3 3 Bladder 5373 2 0.85 78 —
4 4 Penile bulb 294 1 1 85.5 —
5 5 Femora 7049 4 0.8 85.5 —
Normal tissue ring 1 2700 — — 83 —
(0–1.5 cm from PTV) — — — —
Normal tissue ring 2 7203 — — 77 —
(1.5–3 cm from PTV) — — — —
Normal tissue ring 3 9419 — — 65 —
(>3 cm from PTV) — — — — —
Total 44 390 — — — —
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FIG. 1. SALO progression for the brain case, scenario A: (a) stage 1, (b) stage 2, (c) stage 3, and (d) stage 4.
FIG. 2. SALO progression for the brain case, scenario B: (a) stage 1, (b) stage 2, (c) stage 3, and (d) stage 4.
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high priority structures receive improved dose distributions,
particularly the chiasm. Our treatment planners consider the
plan generated by the SALO procedure to be superior to the
one created using pure LO. This is consistent with expecta-
tions, for if the LO plan were more desirable, then the treat-
ment planner would have selected the extreme points on the
tradeoff curves (representing strict prioritization). Scenario
B for the brain case provides an alternate prioritization for
the criteria, and the choices made by the treatment planner
are shown in Fig. 2. In this scenario, the chiasm is of higher
importance than the PTV and is constrained before the
gEUD to the PTV. Finally, Fig. 3(b) shows that the differ-
ence between the two scenarios is relatively small, indicating
a level of robustness of the procedure with respect to inter-
changing the priorities of PTV and chiasm.
III.B. Prostate case
For the prostate case we also distinguished L ¼ 5 major
gEUD criteria, again one for each of the first five structures
listed in Table I. We consider the two alternative priority
scenarios A and B as indicated in that table. Figures 4 and 5
show the L 1 stages of Phase 2 of the SALO procedure for
these two scenarios, while Fig. 6 shows the final set of DVH
curves. These curves show how scenario A compares to (a)
LO and (b) scenario B.
For the prostate case, the procedure progresses in a similar
fashion as for the brain case. However, in this case most of the
clinically desired treatment planning goals was more easily
satisfied. Therefore, instead searching for a clinically feasible
treatment plan, the SALO process as applied here primarily
focused on finding the most desirable treatment plan. For sce-
nario A the first tradeoff is presented in Fig. 4(a). Instead of
just focusing on meeting treatment goals, the treatment plan-
ner can decide how aggressively they wish to treat the PTV.
For the next sets of tradeoffs, a similar line of reasoning is
used, and Fig. 6(a) allows a comparison of the DVHs obtained
by the SALO procedure and pure LO. As in the brain case, a
minor reduction in PTV dose allowed for significant reduc-
tions in dose to critical structures, especially the rectum.
FIG. 3. Brain case: DVHs for treatment plan for (a) scenario A versus LO and (b) scenario A versus scenario B.
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FIG. 4. SALO progression for the prostate case, scenario A: (a) stage 1, (b) stage 2, (c) stage 3, and (d) stage 4.
FIG. 5. SALO progression for the prostate case, scenario B: (a) stage 1, (b) stage 2, (c) stage 3, and (d) stage 4.
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When selecting desired tradeoffs on the plots, it is criti-
cal to pay close attention to the scales on the axes. For
example, in Fig. 4(c) it can be seen that small changes in
the bladder yields relatively large improvements in the
femora. In contrast, in Fig. 4(d) the absolute differences are
very small in magnitude and clinically insignificant due to
the model being very tightly constrained at that stage in the
optimization.
In scenario B for the prostate case the rectum received the
highest priority. In this case, the treatment planner decided
to be slightly more aggressive with respect to the PTV. As
seen in Fig. 6(b), the rectum receives more dose using the
priorities in scenario B, while the femora receives less. How-
ever, these changes are less dramatic than those between
scenario A and pure LO.
III.C. General discussion
Through these processes, we can see how the prioritiza-
tion aspect of LO has been integrated with the interactive
nature of MCO. By combining these two characteristics,
clinically desirable treatment plans were generated system-
atically and efficiently.
Without a treatment planning system with the flexibility
to automate the SALO procedure, this analysis would not be
clinically feasible. For treatment planning systems that allow
plug-ins, implementing the SALO procedure is a straightfor-
ward process, and the clinical benefits could be realized
quite easily. That is, the procedure can be implemented with-
out changing a clinic’s current treatment plan solver.
Programmers need only to set up some background data
structures and a coherent user interface.
The main downside to this type of implementation is that
the usability heavily depends on efficiently approximating
the tradeoff curve between criteria. If the solver is too slow,
the treatment planner could be wasting time waiting for the
tradeoff generation. One way to quicken the solving process
is to solve a model that benefits from previous solution infor-
mation. For the linear program applied to the brain and pros-
tate cases in Sec. III, the model used the most recent solving
iteration’s solution to initialize the solver for the next point
on the tradeoff curve. Another way to speed up the process
FIG. 6. Prostate case: DVHs for treatment plan for (a) scenario A versus LO and (b) scenario A versus scenario B.
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is to design a solver to run on a graphics processing unit
(GPU). When properly designed and coded, models solved
using GPUs allow for significant increases in speed (see,
e.g., Ref. 28).
In practice, it might be beneficial to supplement the SALO
procedure with other dose distribution information. Dose dis-
tribution statistics and DVHs for points along the tradeoff
curves can be generated will little extra computational effort
and would bolster the information presented treatment plan-
ners. Because all calculations up to the first stage tradeoff
assessment can be computed without treatment planner inter-
action, different first stage scenarios can be generated to
influence decisions on the full prioritization. That is, a treat-
ment planner can assess multiple initial tradeoffs before
deciding the relative importances of criteria. Finally, for the
treatment planners interested in the final relative weights
between the different criteria, these values can be recreated
after the SALO approach (see Ref. 1 for this method).
IV. CONCLUSIONS
The SALO procedure provides treatment planners with a
directed, systematic process to treatment plan selection. By
following a physician’s prioritization, the treatment planner
can avoid wasting effort considering clinically inferior treat-
ment plans. The planner is guided by criteria importance, but
given the information necessary to accurately assess the
tradeoff between criteria each stage. When applied to clini-
cal cases, the SALO procedure efficiently generated desira-
ble treatment plans. As treatment planning becomes more
individualized and complex with new techniques and mod-
els, methods that efficiently guide the treatment planner
towards desirable plans will be necessary to implement these
advances at the clinical level.
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